Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADVANCED ENZYME TECHNOLOGIES vs LINK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ADVANCED ENZYME TECHNOLOGIES LINK PHARMA ADVANCED ENZYME TECHNOLOGIES/
LINK PHARMA
 
P/E (TTM) x 29.5 38.0 77.6% View Chart
P/BV x 3.1 1.3 240.7% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 ADVANCED ENZYME TECHNOLOGIES   LINK PHARMA
EQUITY SHARE DATA
    ADVANCED ENZYME TECHNOLOGIES
Mar-24
LINK PHARMA
Mar-24
ADVANCED ENZYME TECHNOLOGIES/
LINK PHARMA
5-Yr Chart
Click to enlarge
High Rs42569 618.1%   
Low Rs23334 682.9%   
Sales per share (Unadj.) Rs55.867.3 82.9%  
Earnings per share (Unadj.) Rs12.2-3.1 -399.0%  
Cash flow per share (Unadj.) Rs15.4-0.7 -2,078.2%  
Dividends per share (Unadj.) Rs5.100-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs118.130.9 382.6%  
Shares outstanding (eoy) m111.824.44 2,518.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.90.8 771.9%   
Avg P/E ratio x26.9-16.8 -160.3%  
P/CF ratio (eoy) x21.4-69.5 -30.8%  
Price / Book Value ratio x2.81.7 167.1%  
Dividend payout %41.60-   
Avg Mkt Cap Rs m36,793228 16,107.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,28455 2,327.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,239299 2,086.7%  
Other income Rs m3706 5,777.2%   
Total revenues Rs m6,608305 2,164.0%   
Gross profit Rs m1,902-7 -29,263.1%  
Depreciation Rs m35210 3,408.3%   
Interest Rs m419 472.6%   
Profit before tax Rs m1,878-19 -9,802.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m509-6 -9,198.9%   
Profit after tax Rs m1,370-14 -10,047.8%  
Gross profit margin %30.5-2.2 -1,402.8%  
Effective tax rate %27.128.9 93.9%   
Net profit margin %22.0-4.6 -481.6%  
BALANCE SHEET DATA
Current assets Rs m8,097115 7,025.4%   
Current liabilities Rs m1,064110 966.4%   
Net working cap to sales %112.71.7 6,470.0%  
Current ratio x7.61.0 726.9%  
Inventory Days Days24855 452.2%  
Debtors Days Days58629 9.2%  
Net fixed assets Rs m7,114144 4,932.3%   
Share capital Rs m22444 503.6%   
"Free" reserves Rs m12,98793 14,013.1%   
Net worth Rs m13,211137 9,636.7%   
Long term debt Rs m7011 657.8%   
Total assets Rs m15,212260 5,862.0%  
Interest coverage x46.6-1.2 -3,890.3%   
Debt to equity ratio x00.1 6.8%  
Sales to assets ratio x0.41.2 35.6%   
Return on assets %9.3-1.9 -490.2%  
Return on equity %10.4-9.9 -104.3%  
Return on capital %14.5-7.1 -204.5%  
Exports to sales %17.60-   
Imports to sales %9.50-   
Exports (fob) Rs m1,097NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m1,0970-   
Fx outflow Rs m5940-   
Net fx Rs m5020-   
CASH FLOW
From Operations Rs m1,4140 -504,889.3%  
From Investments Rs m-6464 -15,962.7%  
From Financial Activity Rs m-592-4 14,554.8%  
Net Cashflow Rs m1730 -57,770.0%  

Share Holding

Indian Promoters % 2.0 51.5 3.8%  
Foreign collaborators % 41.0 0.0 -  
Indian inst/Mut Fund % 20.7 0.0 103,250.0%  
FIIs % 12.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 48.5 117.6%  
Shareholders   66,758 6,151 1,085.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ADVANCED ENZYME TECHNOLOGIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ADVANCED ENZYME TECHNOLOGIES vs LINK PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ADVANCED ENZYME TECHNOLOGIES vs LINK PHARMA Share Price Performance

Period ADVANCED ENZYME TECHNOLOGIES LINK PHARMA S&P BSE HEALTHCARE
1-Day -1.85% -0.86% 0.11%
1-Month -19.03% -4.09% -3.22%
1-Year 17.66% -11.43% 42.65%
3-Year CAGR 4.46% 5.88% 19.86%
5-Year CAGR 16.17% 24.27% 25.90%

* Compound Annual Growth Rate

Here are more details on the ADVANCED ENZYME TECHNOLOGIES share price and the LINK PHARMA share price.

Moving on to shareholding structures...

The promoters of ADVANCED ENZYME TECHNOLOGIES hold a 43.0% stake in the company. In case of LINK PHARMA the stake stands at 51.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES and the shareholding pattern of LINK PHARMA.

Finally, a word on dividends...

In the most recent financial year, ADVANCED ENZYME TECHNOLOGIES paid a dividend of Rs 5.1 per share. This amounted to a Dividend Payout ratio of 41.6%.

LINK PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ADVANCED ENZYME TECHNOLOGIES, and the dividend history of LINK PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.